PI3K/mTOR pathway inhibition overcomes radioresistance via suppression of the HIF1-α/VEGF pathway in endometrial cancer.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Gynecologic Oncology

• Publication date

  2015-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ygyno.2015.04.015PMID 25913131
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Just how accurate are the major risk stratification systems for early-stage endometrial cancer?

  2015cited by this paper
• Endometrial Carcinoma Recurrence Score (ECARS) validates to identify aggressive disease and associates with markers of epithelial-mesenchymal transition and PI3K alterations.

  2014cited by this paper
• Antitumor Activity and Induction of TP53-Dependent Apoptosis toward Ovarian Clear Cell Adenocarcinoma by the Dual PI3K/mTOR Inhibitor DS-7423

  2014cited by this paper
• Anti-tumor activity of olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, in cultured endometrial carcinoma cells

  2014cited by this paper
• Endometrial cancer: a review and current management strategies: part II.

  2014cited by this paper
• Novel PI3K and mTOR Inhibitor NVP-BEZ235 Radiosensitizes Breast Cancer Cell Lines under Normoxic and Hypoxic Conditions

  2014cited by this paper
• PARP1 Is Overexpressed in Nasopharyngeal Carcinoma and Its Inhibition Enhances Radiotherapy

  2013cited by this paper
• NVP-BEZ235, Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor, Prominently Enhances Radiosensitivity of Prostate Cancer Cell Line PC-3

  2013cited by this paper
• Integrated genomic characterization of endometrial carcinoma

  2013influential reference
• PI3K/mTOR Inhibitor PF-04691502 Antitumor Activity Is Enhanced with Induction of Wild-Type TP53 in Human Xenograft and Murine Knockout Models of Head and Neck Cancer

  2013cited by this paper
• Inhibition of DNA Double-Strand Break Repair by the Dual PI3K/mTOR Inhibitor NVP-BEZ235 as a Strategy for Radiosensitization of Glioblastoma

  2013cited by this paper
• Cyclin D1 harboring the T286I mutation promotes oncogenic activation in endometrial cancer.

  2013cited by this paper
• Targeting Hypoxia, HIF-1, and Tumor Glucose Metabolism to Improve Radiotherapy Efficacy

  2012cited by this paper
• Microenvironment and Radiation Therapy

  2012cited by this paper
• Genotype-Dependent Efficacy of a Dual PI3K/mTOR Inhibitor, NVP-BEZ235, and an mTOR Inhibitor, RAD001, in Endometrial Carcinomas

  2012cited by this paper
• Targeting the AKT/GSK3β/cyclin D1/Cdk4 survival signaling pathway for eradication of tumor radioresistance acquired by fractionated radiotherapy.

  2011cited by this paper
• Microsatellite instability predicts clinical outcome in radiation-treated endometrioid endometrial cancer.

  2010cited by this paper
• Genome-wide single-nucleotide polymorphism arrays in endometrial carcinomas associate extensive chromosomal instability with poor prognosis and unveil frequent chromosomal imbalances involved in the PI3-kinase pathway

  2010cited by this paper
• The oncogenic mutation in the pleckstrin homology domain of AKT1 in endometrial carcinomas

  2009cited by this paper
• In vitro and In vivo Radiosensitization with AZD6244 (ARRY-142886), an Inhibitor of Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase 1/2 Kinase

  2009cited by this paper
• Dual phosphoinositide 3-kinase/mammalian target of rapamycin blockade is an effective radiosensitizing strategy for the treatment of non-small cell lung cancer harboring K-RAS mutations.

  2009cited by this paper
• Modulating the tumor microenvironment to increase radiation responsiveness

  2009cited by this paper
• Antiangiogenic Therapy with Mammalian Target of Rapamycin Inhibitor RAD001 (Everolimus) Increases Radiosensitivity in Solid Cancer

  2008cited by this paper
• PIK3CA cooperates with other phosphatidylinositol 3'-kinase pathway mutations to effect oncogenic transformation.

  2008influential reference
• PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis.

  2007cited by this paper
• Phosphatidylinositol 3-Kinase Inhibition by LY294002 Radiosensitizes Human Cervical Cancer Cell Lines

  2006cited by this paper
• Molecular strategies targeting the host component of cancer to enhance tumor response to radiation therapy.

  2006cited by this paper
• HIF-1 and tumour radiosensitivity

  2006cited by this paper
• Cancer targets in the Ras pathway.

  2005cited by this paper
• Inhibition of phosphatidylinositol-3-kinase causes increased sensitivity to radiation through a PKB-dependent mechanism.

  2005cited by this paper
• High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma.

  2005cited by this paper
• Definitive radiotherapy in the management of isolated vaginal recurrences of endometrial cancer.

  2005cited by this paper
• Endometrial cancer

  2005cited by this paper
• Delayed Activation of Insulin-like Growth Factor-1 Receptor/Src/MAPK/Egr-1 Signaling Regulates Clusterin Expression, a Pro-survival Factor*

  2005cited by this paper
• MAPK pathways in radiation responses

  2003cited by this paper
• The role of p53 in chemosensitivity and radiosensitivity

  2003cited by this paper
• VEGF expression and its reguration by p53 gene transfection in endometrial carcinoma cells

  2003cited by this paper
• Stress and Radiation-Induced Activation of Multiple Intracellular Signaling Pathways1

  2003cited by this paper
• The role of p53 in determining sensitivity to radiotherapy

  2003cited by this paper
• The RAS signal transduction pathway and its role in radiation sensitivity

  2003cited by this paper
• P53 and radiation responses

  2003cited by this paper
• Pharmocologic Inhibitors of the Mitogen Activated Protein Kinase Cascade Have the Potential to Interact with Ionizing Radiation Exposure to Induce Cell Death in Carcinoma Cells by Multiple Mechanisms

  2002cited by this paper
• Allelic imbalance in hMLH1 or BRCA2 loci associated with response of cervical and endometrial cancer to radiotherapy.

  2002cited by this paper
• Effect of VEGF receptor inhibitor PTK787/ZK222548 combined with ionizing radiation on endothelial cells and tumour growth

  2001cited by this paper
• The Ras radiation resistance pathway.

  2001cited by this paper
• p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53.

  2000cited by this paper
• Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions.

  2000cited by this paper
• Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma.

  2000cited by this paper
• Blockade of the Vascular Endothelial Growth Factor Stress Response Increases the Antitumor Effects of Ionizing Radiation

  1999cited by this paper
• Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation.

  1999cited by this paper
• Molecular basis of endometrial cancer

  1995cited by this paper
• Radiation sensitivity of endometrial carcinoma in vitro.

  1992cited by this paper
• Calculation of radiation dose enhancement factors for dose enhancement therapy of brain tumours.

  1992cited by this paper
• Establishment and Characterization of Human Endometrial Cancer Cell Lines

  1991cited by this paper
• Analysis of the p53 gene in human uterine carcinoma cell lines.

  1991cited by this paper

• Isoegomaketone improves radiotherapy efficacy and intestinal injury by regulating apoptosis, autophagy and PI3K/AKT/mTOR signaling in a colon cancer model

  2025cites this paper
• PI3K/AKT/mTOR Axis in Cancer: From Pathogenesis to Treatment

  2025cites this paper
• The role of cancer-associated fibroblasts and exosomal miRNAs-mediated intercellular communication in the tumor microenvironment and the biology of carcinogenesis: a systematic review

  2024cites this paper
• Hypoxia and the endometrium: An indispensable role for HIF-1α as therapeutic strategies

  2024cites this paper
• A perspective on tumor radiation resistance following high-LET radiation treatment

  2024cites this paper
• Identification and validation of KIF23 as a hypoxia-regulated lactate metabolism-related oncogene in uterine corpus endometrial carcinoma.

  2024cites this paper
• Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy

  2024cites this paper
• Angiogenesis in endometrial cancer: clinical and biological significance

  2024cites this paper
• Mechanism of salidroside in the treatment of endometrial cancer based on network pharmacology and molecular docking

  2023cites this paper
• HIF-1α promotes virus replication and cytokine storm in H1N1 virus-induced severe pneumonia through cellular metabolic reprogramming

  2023cites this paper
• Cancer-associated fibroblasts in gynecological malignancies: are they really allies of the enemy?

  2023cites this paper
• CD133(+)HIF-1α(−) Expression After Chemoradiotherapy Predicts Poor Prognosis in Rectal Cancer

  2022cites this paper
• Mutant p53 in cancer: from molecular mechanism to therapeutic modulation

  2022cites this paper
• Exosomes on Endometrial Cancer: A Biomarkers Treasure Trove?

  2022cites this paper
• MLLT11-TRIL complex promotes the progression of endometrial cancer through PI3K/AKT/mTOR signaling pathway

  2022cites this paper
• Overcoming chemotherapy resistance in endometrial cancer

  2021cites this paper
• Cancer associated-fibroblast-derived exosomes in cancer progression

  2021cites this paper
• Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer

  2021cites this paper
• Hypoxia-Induced Cancer Cell Responses Driving Radioresistance of Hypoxic Tumors: Approaches to Targeting and Radiosensitizing

  2021cites this paper
• Making radiation therapy more effective in the era of precision medicine

  2020cites this paper
• IL-24 inhibits endometrial cancer cell proliferation by promoting apoptosis through the mitochondrial intrinsic signaling pathway.

  2020cites this paper
• Metastatic role of mammalian target of rapamycin signaling activation by chemoradiotherapy in advanced rectal cancer

  2020cites this paper
• Micheliolide Enhances Radiosensitivities of p53-Deficient Non-Small-Cell Lung Cancer via Promoting HIF-1α Degradation

  2020cites this paper
• Radiosensitising Cancer Using Phosphatidylinositol-3-Kinase (PI3K), Protein Kinase B (AKT) or Mammalian Target of Rapamycin (mTOR) Inhibitors

  2020influential citation
• Effects of Tra2-beta1 on proliferation, apoptosis, and metastasis of hypoxic endometrial carcinoma cell and its correlation with clinicopathological features

  2020cites this paper
• Extracellular vesicle encapsulated microRNA-320a inhibits endometrial cancer by suppression of the HIF1α/VEGFA axis.

  2020cites this paper
• An immune competent orthotopic model of endometrial cancer with metastasis

  2020cites this paper
• Determinants of Sensitivity to Radiotherapy in Endometrial Cancer

  2020influential citation
• Targeted therapies in gynecological cancers: a comprehensive review of clinical evidence

  2020cites this paper
• Hyperoxia sensitizes hypoxic HeLa cells to ionizing radiation by downregulating HIF-1α and VEGF expression

  2020cites this paper
• Rapamycin ameliorates corneal injury after alkali burn through methylation modification in mouse TSC1 and mTOR genes.

  2020cites this paper
• Angiogenesis in endometrial carcinoma: Therapies and biomarkers, current options, and future perspectives.

  2020cites this paper
• Identification of an autophagy-related gene expression prognostic model in endometrial carcinoma patients

  2020cites this paper
• Maintenance BEZ235 Treatment Prolongs the Therapeutic Effect of the Combination of BEZ235 and Radiotherapy for Colorectal Cancer

  2019cites this paper
• Sensitizing endometrial cancer to ionizing radiation by multi-tyrosine kinase inhibition

  2019influential citation
• Oncogenic Y68 frame shift mutation of PTEN represents a mechanism of docetaxel resistance in endometrial cancer cell lines

  2019cites this paper
• The impact of examining VEGF-C expression, D2-40 based detection of LVI, and LVD on the Prediction of Lymph Node Metastasis in Endometrial Carcinoma.

  2019cites this paper
• The use of buparlisib as a radiosentisiser: What about toxicity?

  2019cites this paper
• Anti-tumor activity of dual inhibition of phosphatidylinositol 3-kinase and MDM2 against clear cell ovarian carcinoma.

  2019cites this paper
• The combination of temsirolimus and chloroquine increases radiosensitivity in colorectal cancer cells.

  2019cites this paper
• Hypoxia inducible factor-1α/B-cell lymphoma 2 signaling impacts radiosensitivity of H1299 non-small cell lung cancer cells in a normoxic environment

  2019cites this paper
• Metformin may offer no protective effect in men undergoing external beam radiation therapy for prostate cancer

  2019cites this paper
• Epithelial to Mesenchymal Transition and Cell Biology of Molecular Regulation in Endometrial Carcinogenesis

  2019cites this paper
• Role of metabolism in cancer cell radioresistance and radiosensitization methods

  2018cites this paper
• Ruscogenin suppressed the hepatocellular carcinoma metastasis via PI3K/Akt/mTOR signaling pathway.

  2018cites this paper
• NeoTYPE TM Analysis Discovery Profile Client 1234 Sample Client

  2018cites this paper
• SN-38 Acts as a Radiosensitizer for Colorectal Cancer by Inhibiting the Radiation-induced Up-regulation of HIF-1α

  2018cites this paper
• Insulin-like growth factor-1 receptor knockdown enhances radiosensitivity via the HIF-1α pathway and attenuates ATM/H2AX/53BP1 DNA repair activation in human lung squamous carcinoma cells.

  2018cites this paper
• Identification of protein biomarkers and signaling pathways associated with prostate cancer radioresistance using label-free LC-MS/MS proteomic approach

  2017cites this paper
• 20(s)-Protopanaxadiol (PPD) increases the radiotherapy sensitivity of laryngeal carcinoma.

  2017cites this paper
• Molecular targeting of hypoxia in radiotherapy☆

  2017cites this paper
• The long noncoding RNA‐ROR promotes the resistance of radiotherapy for human colorectal cancer cells by targeting the p53/miR‐145 pathway

  2017cites this paper
• New drug development in head and neck squamous cell carcinoma: The PI3-K inhibitors.

  2017cites this paper
• Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation

  2017cites this paper
• Coexistent Activating Mutations in the Ras / PI 3 k Pathway Potentiate Malignant Transformation of Epithelial Cells in Endometrial and Other Tissues

  2016cites this paper
• Perspectives on targeting the phosphatidylinositol 3-kinase pathway for personalized medicine in endometrial and ovarian cancers

  2016cites this paper
• Tissue and imaging biomarkers for hypoxia predict poor outcome in endometrial cancer

  2016cites this paper
• Hypoxia-inducible factor-1alpha: A promising therapeutic target in endometriosis.

  2016cites this paper
• Characterization of TP53 and PI3K signaling pathways as molecular targets in gynecologic malignancies

  2016cites this paper
• Cancer stem cells and signaling pathways in radioresistance

  2015cites this paper
• Fenofibrate inhibits the expression of VEGFC and VEGFR-3 in retinal pigmental epithelial cells exposed to hypoxia

  2015cites this paper
• Expression and clinical correlation of NGAL and VEGF in endometrial carcinoma

  year unknowncites this paper